Unapproved eye treatments get yanked by FDA

NEW YORK The Food and Drug Administration has told companies to stop selling eye solutions for use during surgery and for treating lesions without regulatory approval, citing dangerous side effects.

The drugs include ophthalmic balanced salt solutions for the eyes and topical drugs containing the papaya-based compound papain.

A number of companies have sold the unapproved eye drugs, including Baxter International and Hospira.